Epizyme Story Overview

EPZM -- USA Stock  

USD 9.90  0.15  1.49%

Macroaxis does not monitor all media channels or aggregates social signals for Epizyme. But even though we do not provide professional-grade financial sentiment analysis on Epizyme, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Epizyme. Additionally see Epizyme Hype Analysis, Epizyme Correlation and Epizyme Performance.
Acquisition by Michael Giordano of 25000 shares of Epizyme subject to Rule 16b-3
Filed transaction by Epizyme Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Epizyme Inc insider trading alert for grant of stock option (right to buy) by Michael Giordano, the corporate stakeholder, on March 12, 2018. This event was filed by Epizyme Inc with SEC on 2018-03-12. Statement of changes in beneficial ownership - SEC Form 4

Story Momentum

This media report from MacroaxisInsider distributed on March 12, 2018 was a factor to the next trading day price appreciation.The overall trading delta against the next closing price was 3.25% . The overall trading delta when the story was published against the current closing price is 45.53% .

Similar stores for Epizyme

Have a look on data Epizyme, Inc. , Black Box Corporation , Summit Semiconductor ...Thestreet News
The Stock Street Full coverage
few days ago at http://finbulletin.com 
Bouncing back from collapse Snap-on Incorporated , Epizyme, Inc.
news
FinBulletinFull coverage
over a week ago at http://news.cmlviz.com 
EPZM Exactly The Technical Indicator That Has Worked and When it Worked in Epizyme Inc
news
CML NewsFull coverage
over two weeks ago at http://www.thecoinguild.com 
Stock in the News Investors Keen on Epizyme, Inc. as it Makes Headlines With Moves
news
The Coin GuildFull coverage
over two weeks ago at www.macroaxis.com 
Exercise or conversion by Robert Copeland of 5000 shares of Epizyme subject to Rule 16b-3
Macroaxis News
Filed transaction by Epizyme Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over three weeks ago at http://thewellesleysnews.com 
Stock-research Ratings Arotech Corporation , Epizyme, Inc.
news
Analyst JournalFull coverage
over three weeks ago at http://kreviewer.com 
As Epizyme Market Value Rose, Holder Oracle Investment Management Upped Its Holding Meridian ...
news
K ReviewerBetter Buy The Home Depot vs. Sherwin-Williams Motley FoolFull coverage
over a month ago at http://www.thecoinguild.com 
Market Review Investors Taking a Second Look at Epizyme, Inc. After Recent Market Moves
news
The Coin GuildAnalyst Earnings Estimates Screen Epizyme, Inc. Analyst JournalWeekly Research Analysts Ratings Updates for Epizyme PressOracleYou Should Not Miss Epizyme In 2018 Seeking AlphaFull coverage
over a month ago at http://www.thecoinguild.com 
Market in the News Investors Keen on Epizyme, Inc. as it Makes Headlines With Moves
news
The Coin GuildFull coverage
over a month ago at http://www.thecoinguild.com 
Shares Focus Investors Keen on Epizyme, Inc. as it Makes Waves With Moves
news
The Coin GuildFull coverage
over a month ago at http://news.cmlviz.com 
Stock Alert and Holding Pattern Epizyme Inc Price Volatility Hits An Inflection Point
news
CML NewsFull coverage
over three months ago at http://markets.businessinsider.com 
Epizyme Presents Encouraging Phase 2 Data of Tazemetostat for Malignant Mesothelioma at ASCO
businessinsider News
Markets InsiderFull coverage
over three months ago at http://thewellesleysnews.com 
Analyst Stock Recommendations For Epizyme, Inc. , Iconix Brand Group, Inc.
news
Analyst JournalEpizyme, Inc. finishes with -7.24 percent while stock price is worth at 13.77 Nasdaq Fortune Epizyme, Inc. Rises to 14.88 The Frugal ForagerFull coverage

Price to Book

Price to Book Comparative Analysis

Epizyme is currently under evaluation in price to book category among related companies. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is accounting value of assets minus liabilities.

Peers

Epizyme Related Equities

EDGE  11.53 %   
0%
100.0%
DMPI  9.81 %   
0%
85.0%
ECYT  5.21 %   
0%
45.0%
DRNA  4.06 %   
0%
35.0%
CO  2.43 %   
0%
21.0%
DNLI  0.57 %   
0%
4.0%
DOVA  1.26 %   
10.0%
0%
EARS  1.64 %   
14.0%
0%
DVAX  1.86 %   
16.0%
0%
NK  4.3 %   
37.0%
0%
Additionally see Epizyme Hype Analysis, Epizyme Correlation and Epizyme Performance. Please also try Crypto Portfolio Optimizer module to optimize portfolio of digital coins and token across multiple currency and exchanges.
Search macroaxis.com